Literature DB >> 23322609

Low-frequency enzyme replacement therapy in late-onset Pompe disease.

Dar-Shong Lin, Ming-Fu Chiang, Che-Sheng Ho, Chung-Der Hsiao, Chang-Yi Lin, Nien-Lu Wang, Chih-Kuang Chuang, Yu-Wen Huang, Po-Chun Chang, Hsuan-Liang Liu.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23322609     DOI： 10.1002/mus.23658

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  2 in total

1.  36-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry.

Authors:  Olivier Scheidegger; Daniela Leupold; Rafael Sauter; Oliver Findling; Kai Michael Rösler; Thomas Hundsberger
Journal:  J Neurol       Date:  2018-09-19       Impact factor: 4.849

2.  Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis.

Authors:  Thomas Hundsberger; Kai M Rösler; Oliver Findling
Journal:  J Neurol       Date:  2014-06-13       Impact factor: 4.849
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.